US ENDOCRINOLOGY – VOLUME 8 ISSUE 2 – WINTER 2012
Using Professional Continuous Glucose Monitoring to Modify Eating Behavior in Patient on ‘Heart Healthy’ Diet
Behavioral Factors Influencing Health Outcomes in Youth with Type 1 Diabetes
Adherence to medical regimen is often identified as a hallmark modifiable factor that impacts health outcomes for those with chronic medical illnesses.
Fatigue in Adults with Type 2 Diabetes – An Overview of Current Understanding and Management Approaches
Patients with type 2 diabetes commonly experience fatigue, which may be incapacitating and adversely affect self-care regimens.,sup>1–7 Fatigue is a perplexing problem for healthcare providers.8 Wessely suggests that because fatigue is a non-specific and universal symptom, chronic fatigue is challenging to diagnose and treat.9 Fatigue researchers do not have a standardised definition, measurement approach, or […]
Diabetes and Oral Health
Diabetes and Oral Health—Current Concepts Regarding Periodontal Disease and Dental Caries
The increased morbidity and mortality associated with diabetes are well known to health care providers. Retinopathy, nephropathy, macrovascular disease, neuropathy, and poor wound healing can have a major impact on the lives of patients with diabetes. These complications take an enormous personal and financial toll.
AGE, RAGE, and Diabetic Nephropathy
Diabetic nephropathy (DN) has become the most frequent cause of terminal renal failure in western countries. Its natural course has been well described and includes the development of functional and structural degenerative changes in the kidney. More specifically, glomerular membrane thickening, mesangial matrix expansion, microvascular changes, arteriolar hyalinosis, and tubular degeneration are characteristic aspects of […]
Statin Drug Interactions in Patients with Comorbidities and on Multiple Medications
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, and an overwhelming body of clinical evidence has demonstrated the efficacy of statin treatment in the prevention of this condition. Therapeutic goals in the prevention of CVD include management of dyslipidemia and of its complications such as hypertension and diabetes. Statins are the most widely […]
Temozolomide in the Treatment of Aggressive Pituitary Tumors— An Overview of Existing Knowledge and Future Perspectives
Pituitary tumors are common, with an estimated prevalence of 16.7 % in the general population based on imaging and autopsy studies.1 Clinically significant pituitary tumors are more prevalent than previously recognized, with one case per 1,000–1,300 people.2,3 The majority of pituitary tumors are indolent, slow-growing neoplasms.
Growth Hormone Deficiency During the Transition Phase
The transition period is the span of time in which people complete their somatic and psychological development after reaching their full stature (also known as late teenage years, post-adolescence or young adulthood). It starts in late puberty and comes to an end at around 25 years of age, thus lasting from three to 10 years. […]
Witnessing a New Era? – The Emerging Role of Targeted Drugs in the Medical Treatment of Advanced Medullary and Anaplastic Thyroid Cancer
Malignancies of the thyroid can be classified as either of follicular cell origin or parafollicular C-cell origin.
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!